Propose. Together, members of the community can propose to study
and fund a promising treatment,
evaluate the approach, and decide which ones to pursue next.

Develop. Vibe Bio uses the money raised from community activities and dedicated funds and approved by the community to perform drug development work. This includes clinical trials, pre-clinical development, and manufacturing, to name a few. The economics of each of these drug research programs is shared between the disease-specific patient community and the community.

Community. Patients, scientists, and investors come together to make up the Vibe Bio community, a group of drug development experts and patients, to identify high-potential medicines.

Sustain. As these treatments are commercialized or are licensed by other pharmaceutical companies, they return capital to the community and patient advocacy organizations. Our community can use those returns to fund future projects.

How Vibe Bio Works


For too many patients with overlooked diseases, the time it would take to develop a cure is longer than the time they have left.

For the first time, we're developing and scaling treatments for rare disorders — and giving patient communities unprecedented control in the process.

To do that, we partner with patient groups to develop treatments that otherwise would languish on a shelf. We leverage innovative sources of funding and build a community of scientists and fellow patients so that no one has to forge the path to a cure alone.

Biotech Innovators

Vibe Bio partners with an expansive ecosystem of industry thought leaders reshaping the biotech landscape across research and development, clinical trials and funding. Our mission: every cure for every community requires a diverse set of perspectives, expertise and passion.

Interested in learning more and joining the cause? Send our team an email at or connect with us on social!

Chelsea's Hope

Chelsea’s Hope is a foundation dedicated to finding a cure for Lafora disease, which causes seizures and cognitive and physical decline. Most patients pass away within 10 years of the onset of symptoms. Vibe Bio is partnering with Chelsea’s Hope to start new clinical trials and finally find a cure. Together, we have founded New Hope, a biotech company that will build on promising research into potential therapies for Lafora disease to finally get patients the treatment they need. Read more about Chelsea’s Hope.


What is Vibe Bio?

Vibe Bio is a community of patients, scientists, and partners committed to identifying promising treatments to overlooked diseases, funding their development in innovative ways, and giving patient communities unprecedented ownership over the new treatments they need.

What is Vibe Bio
working to cure?

Vibe Bio partners with patient communities to find treatments for rare and overlooked disorders. Our first foundational partnership — Chelsea’s Hope — will help develop treatments for rare disorders like Lafora disease.

How does Vibe Bio review and vet projects before funding them?

Together, members of the community can propose to study and fund a promising treatment, evaluate the approach, and approve which ones Vibe pursues next. In this process, independent drug development experts (scientists & researchers) review projects proposed by the community. Their assessments are synthesized and inform the feasibility and potential associated with proposed projects.

How do I partner with Vibe Bio?

We are always eager to connect with patients, families, advocates, scientists, biopharma companies, and others who are as passionate as we are about finding treatments for overlooked diseases. Please contact us here to let us know that you’re interested in working together.

How do I join the
Vibe Bio community?

You can join the Vibe community by joining our Discord or partnering with us. If you’re interested in working together or want more information about our model, please fill out this form.

Why DeSci?

Decentralized science creates a more open, equitable, and transparent research and development environment that relies on distributed communities of scientists & patients. Open sharing of data creates enables anyone to participate in the drug development process. DeSci encourages collaboration between researchers from all around the world allowing for more innovation and discovery.

What does it cost to participate in the community?

For patients and drug developers, there is no financial cost to participate in the Vibe Bio community.

Where does the money come from to develop a given medicine?

Vibe Bio raises money through community activities (e.g. courses, events, etc.) and dedicated funds, which our community helps allocate to perform drug development work. As the treatments we advance are commercialized or are licensed by pharmaceutical companies, they return capital to the Vibe community and patient advocacy organizations. Our community can use those returns to fund future projects.

How does the volatility of biotech impact your ability to fund drug development?

Vibe Bio has access to capital via community activities and dedicated funds, in addition to external investors. The community approves the expenditure of dollars from our pool for drug development programs.

Who does the actual drug development?

The drug development work is performed by experienced drug developers, scientists, contract partners (e.g. contract research organizations, contract manufacturing organizations), and medical establishments (e.g. for clinical trials).

Why are you focused on rare diseases?

1 in 10 Americans suffer from a rare disease. Vibe Bio is focused on rare diseases because of the urgent need for cures and because of the vibrant and motivated communities who are already organized in pursuing those cures. Vibe Bio is funding and advancing projects that currently are not getting the funding and attention they deserve.

What inspired this community-based model for drug development?

When Vibe Bio founder Alok Tayi and his wife had their first child, she was born very sick and spent a long time suffering in the hospital. The biology behind her conditions is well understood, but there were no therapeutic options available to her. They felt frustrated and alone.

Through that experience, Alok connected with other families with sick children in the NICU and realized that the problem with drug development — especially for rare diseases — is not that we can’t find cures; it’s that we don’t have the funding to do it. That’s what motivated him to create Vibe Bio, which will give patients ownership over the drug development process and a community to support them along the way.